T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2183-2191

  Tang, Yi Wei ^a,b   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

cytotoxic T lymphocytes; IFN ; IL 12; IL 4; vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031010847     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119391     Document Type: Article

References (66)

1. Hall, C.B. 1994. Prospects for a respiratory syncytial virus vaccine. Science (Wash. DC). 265:1393-1394.
2. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and CE. Stewart. 1979. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
3. Kim, W.H., J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol 89:422-434.
4. Fulginiti, V.A., J.J. Eller, O.F. Sieber, J.W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. Respiratory virus immunization - a field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
5. Chin, J., R.L. Magoffin, L.A. Shearer, J.H. Schieble, and E.H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
6. Friedewald, W.T., B.R. Forsyth, C.B. Smith, M.A. Gharpure, and R.M. Chanock. 1968. Low-temperature-grown RS virus in adult volunteers. J. Am. Med. Assoc. 204:142-146.
7. Kim, W.H., J.O. Arrobio, G. Pyles, C.D. Brandt, E. Camargo, R.M. Chanock, and R.H. Parrott. 1971. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatric. 48:745-755.
8. Wright, P.F., J. Mills, and R.M. Chanock. 1971. Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J. Infect. Dis. 124: 505-511.
9. Murphy, B.R., S.L. Hall, A.B. Kulkarni, J.E. Crowe, Jr., P.L. Collins, M. Connors, R.A. Karron, and R.M. Chanock. 1994. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:13-36.
10. Mosmann, T.R., H. Cherwinski, M.W. Bond. M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. lmmunol. 136: 2348-2357.
11. Mosmann, T.R., and R.I. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
12. - cells that make Th2 cytokines and help B cells. Science (Wash. DC). 260:1802-1805.
13. Croft, M., L. Carter, S.L. Swain, and R.W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715-1728.
14. Ferrick, D.A., M.D. Schrenzel, T. Mulvania, B. Hsieh, W.G. Ferlin, and H. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1-and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature (Lond.). 373:255-257.
15. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-577.
16. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
17. Scott, P., P. Natovitz, and A. Sher. 1986. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J. Immunol. 137:1017-1021.
18. Shankar, A.H., and R.G. Titus. 1995. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J. Exp. Med. 181:845-855.
19. Sadick, M.D., R.M. Locksley, C. Tubbs, and H.V. Raff. 1986. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J. Immunol. 136: 655-661.
20. Heinzel, F.P., M.D. Sadick, B.J. Holaday, R.L. Coffman, and R.M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence of expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
21. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292.
22. Sher, A., R.L. Coffman, S. Hieny, and A.W. Cheever. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145: 3911-3916.
23. Romani, L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni. 1991. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:4647-4654.
24. Yamamura, M., K. Uyemura, R.J. Deans, K. Weinberg, T.H. Rea, B.R. Bloom, and R.L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (Wash. DC). 254:277-279.
25. Griffin, D.E., and B.J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:275-281.
26. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759-765.
27. Graham, B.S., G.S. Henderson, Y.W. Tang, X. Lu, K.M. Neuzil, and D.C. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
28. Tang, Y.W., and B.S. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1953-1958.
29. Tang, Y.W., and B.S. Graham. 1995. Interleukin 12 treatment during immunization elicits a Th1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172: 734-738.
30. Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science (Wash. DC). 271: 987-989.
31. Graham, B.S., M.D. Perkins, P.F. Wright, and D.T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162.
32. Schoenhaut, D.S., A.O. Chua, A.G. Wolitzky, P.M. Quinn,C.M. Dwyer, W. McComas, P.C. Familletti, M.K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433-3440.
33. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074-3081.
34. Ohara, J., and W.E. Paul. 1985. B cell stimulatory factor (BSF-1): production of a monoclonal antibody and molecular characterization. Nature (Lond.). 315:333-336.
35. Dialynas, O.P., Z.S. Quan, K.A. Wall, A. Pierres, J. Quintanes, M.R. token, M. Pierres, and F.W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445-2451.
36. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
37. Graham, B.S., L.A. Bunton, P.P. Wright, and D.T. Karzon. 1991. The role of T cell subsets in the pathogenesis of primary infection and reinfection with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026-1033.
38. Kim, W.H., S.L. Leikin, J.O. Arrobio, C.D. Brandt, R.M. Chanock, and R.H. Parrott. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:75-78.
39. Alwan, W.H., W.J. Kozlowska, and P.J.M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
40. + T cells. J. Virol. 66:7444-7451.
41. Alwan, W.H., P.M. Record, and P.J.M. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific tor individual respiratory syncytial virus proteins. J. Immunol. 150:5211-5218.
42. Audibert, P.M., and L.D. Lise. 1994. Adjuvants: current status, clinical perspectives and future prospects, Immunol. Today. 14:281-284.
43. Playfair, J.H.L, and J.B. DeSouza. 1987. Recombinant gamma interferon is potent adjuvant for a malaria vaccine in mice. J. Clin. Immunol. 67:5-10.
44. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulation factor, a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
45. Stern, A.S., F.J. Podlaski, J.D. Hulmes, Y.-C.E. Pan, P.M. Quinn, A.G. Wolitzky, P.C. Familletti, D.L. Stremlo, T. Truitt, R. Chizzonite, and M.K. Gately. 1990. Purification of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 87:6808-6812.
46. Atbnso, L.C.C., T. M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science (Wash. DC). 263:235-237.
47. Wynn, T.A., I. Eltoum, I.P. Oswald, A.W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophy'actically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.
48. Wynn, T.A., A.W. Cheever, D. Jankovic, R.W. Poindexter, P. Casper, F.A. Lewis. and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (Lond.). 376:594-596.
49. Schijns, V.E.C.J., B.L. Haagmans, and M.C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155:2525-2532.
50. Cannon, M.J., P.J.M. Openshaw, and B.A. Askonas. 1988. Cytotoxic T lymphocytes clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
51. Taylor, G., L.H. Thomas, S.G. Wyld, J. Furze, P. Sopp, and C.J. Howard. 1995. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J. Virol. 69:6658-6664.
52. Bangham, C.R.M., and A.J. McMichael. 1986. Specific cytotoxic T cells recognize B cells persistently infected with respiratory syncytial virus. Proc. Natl. Acad. Sci. USA. 83:9183-9187.
53. Chiba, Y., T. Minagawa, K. Mito, A. Nakane, K. Suga, T. Honjo, and T. Nakao. 1987. Effect of breast feeding on responses of Interferon and virus-specific lymphocyte transformation in infants with respiratory syncytial virus infection. J. Med. Virol. 21:7-14.
54. Isaacs, D., C.R.M. Bangham, and A.J. McMichael. 1987. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. ii:769-771.
55. Orange, J.S., S.F. Wolf, and C.A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152: 1253-1264.
56. Orange, J.S., T.P. Salazar-Mather, S.M. Opal, R.L. Spencer, A.H. Miller, B.S. McEwen, and C.A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-914.
57. Havran, W.L., and J.P. Allison. 1988. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature (Lond.). 335:443-445.
58. + T cells. J. Exp. Med. 172:1225-1231.
59. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Muramori, K. Matsumoto, J.A. Bluestone, and K. Nomoto. 1992. A protective role of gamma/ delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175:49-56.
60. Barnes, P.P., C.L. Grisso, J.S. Abrams, H. Band, T.H. Rea, and R.L. Modlin. 1992. Gamma/delta T lymphocytes in human tuberculosis. J. Infect. Dis. 165:506-512.
61. Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, and S.H. Kaufmann. 1993. Different roles of alpha/beta and gamma/delta T cells in immunity against an intracellular bacterial pathogen. Nature (Lond.). 365:53-56.
62. Skeen, M.J., and H.K. Ziegler. 1993. Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection, J. Exp. Med. 178:971-984.
63. Fu, Y.X., C.E. Roark, K. Kelly, D. Drevets, P. Campbell, R. O'Brien, and W. Born. 1994. Immune protection and control of inflammatory tissue necrosis by gamma/delta T cells. J. Immunol. 153:3101-3115.
64. Haas, W., P. Pereira, and S. Tonegawa. 1993. Gamma/delta cells. Annu. Rev. Immunol. 11:637-685.
65. Cesano, A., S. Visonneau, S.C. Clark, and D. Santoli. 1993. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J. Immunol. 151:2943-2957.
66. Skeen, M.J., and H.K. Ziegler. 1995. Activation of gamma/delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 154:5832-5841.